Sporadic tumors (including breast cancer, prostate cancer, neuroendocrine tumors, and others) occurring as single tumors in the absence of any other findings of MEN4 frequently contain a somatic pathogenic variant in CDKN1B that is not present in the germline. This evidence concerns the gene CDKN1B and Familial prostate cancer.